Prospective Evaluation of the First Mitomycin C Augmented Needle Revision in Patients With Failed Nonpenetrating Deep Sclerectomy.
Gutiérrez-Ortiz Consuelo, Moreno-Salgueiro Agustín, Rodrigo-Rey Sara, González-Mesa Ana, Pérez-Rico Consuelo
This study found mitomycin C-augmented needle revision for failed deep sclerectomy significantly lowers IOP, with a post-procedure day-one IOP under 8 mmHg predicting higher success.